Metamizol Stada

Metamizole sodium, the active ingredient in Metamizol Stada, is a pyrazolone analgesic presented as an oral formulation for systemic use. It is employed to relieve mild to moderate pain, manage postoperative discomfort, reduce fever, and treat colic or visceral pain in adult patients.

GNH USA supplies Metamizol Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for each batch, ensuring reliable supply chains across multiple regions.

Metamizole sodium is used to manage pain and fever by acting on prostaglandin‑mediated pathways.

- Mild to moderate pain: provides analgesia to reduce discomfort in acute or chronic settings. - Post‑operative pain: helps control surgical pain during the recovery period. - Fever: lowers elevated body temperature associated with infection or inflammation. - Colic and visceral pain: alleviates spasm‑related discomfort in the gastrointestinal tract.

Adverse reactions may occur with Metamizole sodium use.

Common Side Effects: - Nausea or vomiting - Dizziness or light‑headedness - Headache - Mild skin rash - Transient hypotension - Gastro‑intestinal discomfort

Serious or Rare Side Effects: - Agranulocytosis (severe drop in white blood cells) - Anaphylactic shock or severe allergic reactions - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Hepatic dysfunction - Renal impairment - Blood dyscrasias such as thrombocytopenia

Before prescribing Metamizole sodium, consider the following safety measures.

- Assess renal and hepatic function: adjust use in patients with impairment. - Monitor complete blood count: early detection of agranulocytosis is essential. - Avoid in known hypersensitivity: discontinue immediately if allergic signs appear. - Use with caution in the elderly: increased susceptibility to hypotension and adverse effects. - Pregnancy and breastfeeding: safety not established; consider alternative therapies. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Metamizole sodium can interact with other medicines; awareness of key interactions helps prevent complications.

Major Interactions (Avoid): - Concurrent use with other myelotoxic agents: heightened risk of agranulocytosis. - Combination with other NSAIDs or COX inhibitors: increased gastrointestinal toxicity. - Co‑administration with ACE inhibitors: may exacerbate hypotensive effects.

Moderate Interactions (Monitor Closely): - Warfarin: potential enhancement of anticoagulant effect. - Lithium: possible increase in serum lithium concentrations. - Methotrexate: may raise risk of toxicity and bone marrow suppression.